Managing patients with severe Alzheimer disease


The management of severe Alzheimer disease may include the use of cholinesterase inhibitors and/or memantine, and atypical antipsychotics for patients with severe agitation, aggression and psychosis, according to the Third Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (Herrmann & Gauthier. Can Med Assoc J 2008;179:1279-1287; free text at See also Patterson et al. Can Med Assoc J 1999;160:1738-1742).

It takes 30 seconds

Recommend to a Colleague

Related Posts

Go back to home page